» Articles » PMID: 21587164

Intraluminal Middle Cerebral Artery Occlusion (MCAO) Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Mice

Overview
Journal J Vis Exp
Date 2011 May 19
PMID 21587164
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is the third leading cause of death and the leading cause of disability in the world, with an estimated cost of near $70 billion in the United States in 2009. The intraluminal middle cerebral artery occlusion (MCAO) model was developed by Koizumi in 1986 to simulate this impactful human pathology in the rat. A modification of the MCAO method was later presented by Longa. Both techniques have been widely used to identify molecular mechanisms of brain injury resulting from ischemic stroke and potential therapeutic modalities. This relatively noninvasive method in rats has been extended to use in mice to take advantage of transgenic and knockout strains. To model focal cerebral ischemia, an intraluminal suture is advanced via the internal carotid artery to occlude the base of the MCA. Retracting the suture after a specified period of time mimics spontaneous reperfusion, but the suture can also be permanently retained. This video will be demonstrating the two major approaches for performing intraluminal MCAO procedure in mice in a stepwise fashion, as well as providing insights for potential drawbacks and pitfalls. The ischemic brain tissue will subsequently be stained by 2,3,5-triphenyltetrazolium chloride (TTC) to evaluate the extent of cerebral infarction.

Citing Articles

Reduced ischemia-reperfusion oxidative stress injury by melatonin and N-acetylcysteine in the male rat brain.

Sabbaghziarani F, Soleimani P, Eynshikh F, Zafari F, Aali E IBRO Neurosci Rep. 2024; 17:131-137.

PMID: 39175643 PMC: 11339246. DOI: 10.1016/j.ibneur.2024.07.004.


Comprehensive immune modulation mechanisms of Angong Niuhuang Wan in ischemic stroke: Insights from mass cytometry analysis.

Yao Y, Ni W, Feng L, Meng J, Tan X, Chen H CNS Neurosci Ther. 2024; 30(7):e14849.

PMID: 39075660 PMC: 11286541. DOI: 10.1111/cns.14849.


The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury.

Selvaraj S, Weerasinghe L Cent Nerv Syst Agents Med Chem. 2024; 25(1):20-38.

PMID: 38676493 DOI: 10.2174/0118715249291999240418112531.


Investigating the ID3/SLC22A4 as immune-related signatures in ischemic stroke.

Lu D, Cai H, Li Y, Chang W, Liu X, Dai Q Aging (Albany NY). 2023; 15(24):14803-14829.

PMID: 38112574 PMC: 10781493. DOI: 10.18632/aging.205308.


Distinctions between the Koizumi and Zea Longa methods for middle cerebral artery occlusion (MCAO) model: a systematic review and meta-analysis of rodent data.

Li Y, Tan L, Yang C, He L, Liu L, Deng B Sci Rep. 2023; 13(1):10247.

PMID: 37353569 PMC: 10290095. DOI: 10.1038/s41598-023-37187-w.


References
1.
Tureyen K, Vemuganti R, Sailor K, Dempsey R . Ideal suture diameter is critical for consistent middle cerebral artery occlusion in mice. Neurosurgery. 2005; 56(1 Suppl):196-200. DOI: 10.1227/01.neu.0000144490.92966.59. View

2.
Kapinya K, Prass K, Dirnagl U . Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism?. Neuroreport. 2002; 13(11):1431-5. DOI: 10.1097/00001756-200208070-00017. View

3.
Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartkowski H . Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986; 17(6):1304-8. DOI: 10.1161/01.str.17.6.1304. View

4.
Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

5.
. Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989; 20(10):1407-31. DOI: 10.1161/01.str.20.10.1407. View